US Stock MarketDetailed Quotes

ACRS Aclaris Therapeutics

Watchlist
  • 4.070
  • +0.250+6.54%
Close Nov 29 13:00 ET
  • 4.210
  • +0.140+3.44%
Post 17:01 ET
435.44MMarket Cap-7826P/E (TTM)

Aclaris Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-53.18%4.35M
47.99%2.77M
-5.14%2.4M
5.03%31.25M
126.62%17.57M
-51.19%9.28M
22.32%1.87M
73.98%2.53M
340.05%29.75M
416.52%7.75M
Operating revenue
-53.18%4.35M
47.99%2.77M
-5.14%2.4M
5.95%31.25M
131.55%17.57M
-51.12%9.28M
24.77%1.87M
77.65%2.53M
344.27%29.5M
415.84%7.59M
Cost of revenue
-70.61%2.41M
19.91%1.91M
-1.55%1.84M
51.18%18.08M
324.57%6.43M
-0.38%8.19M
49.06%1.59M
61.82%1.87M
153.77%11.96M
31.77%1.51M
Gross profit
77.80%1.94M
209.39%857K
-15.33%558K
-25.99%13.17M
78.59%11.14M
-89.90%1.09M
-39.78%277K
121.14%659K
768.75%17.79M
1,672.44%6.24M
Operating expense
-62.15%11.61M
-58.52%13.51M
-46.81%16.69M
25.78%129.48M
23.54%34.86M
4.09%30.67M
31.05%32.57M
53.77%31.38M
52.67%102.95M
34.08%28.22M
Selling and administrative expenses
-16.84%5.65M
-34.87%4.75M
-22.14%6.84M
23.73%31.1M
14.95%8.21M
16.94%6.8M
20.10%7.3M
44.12%8.79M
6.41%25.13M
2.92%7.15M
-General and administrative expense
-16.84%5.65M
-34.87%4.75M
-22.14%6.84M
23.73%31.1M
14.95%8.21M
16.94%6.8M
20.10%7.3M
44.12%8.79M
6.41%25.13M
2.92%7.15M
Research and development costs
-75.05%5.96M
-65.35%8.76M
-56.41%9.85M
26.44%98.38M
26.45%26.65M
0.93%23.88M
34.59%25.28M
57.88%22.59M
77.60%77.81M
49.43%21.07M
Operating profit
67.31%-9.67M
60.82%-12.65M
47.49%-16.13M
-36.59%-116.31M
-7.91%-23.72M
-58.42%-29.58M
-32.39%-32.29M
-52.77%-30.72M
-30.24%-85.15M
-6.21%-21.98M
Net non-operating interest income expense
-14.03%1.99M
2.32M
Non-operating interest income
-14.03%1.99M
----
----
----
----
--2.32M
----
----
----
----
Other net income (expense)
104.72%94K
-38.79%1.67M
-131.67%-810K
1,665.91%27.47M
598.23%28.18M
-55.95%-1.99M
-29.44%2.73M
94.08%2.56M
93.12%-1.75M
-167.93%-5.66M
Special income (charges)
59.86%-800K
-141.75%-200K
-450.00%-2.8M
503.34%18.96M
377.06%19.67M
9.41%-1.99M
-85.91%479K
-33.33%800K
80.69%-4.7M
-222.73%-7.1M
-Less：Restructuring and merger&acquisition
-52.94%800K
113.33%200K
450.00%2.8M
-672.34%-26.9M
-470.42%-26.3M
-22.73%1.7M
55.88%-1.5M
33.33%-800K
-80.69%4.7M
222.73%7.1M
-Less:Impairment of capital assets
----
----
----
--6.63M
----
----
----
----
--0
----
-Write off
--0
--0
----
--1.31M
--0
--293K
--1.02M
----
--0
--0
Other non- operating income (expenses)
--894K
-16.83%1.87M
13.20%1.99M
188.83%8.51M
----
----
386.15%2.25M
1,389.83%1.76M
357.97%2.95M
1,522.47%1.44M
Income before tax
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-2.23%-88.85M
93.28%-1.86M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
Income tax
-367K
0
Net income
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
Net income continuous Operations
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
Minority interest income
Net income attributable to the parent company
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
74.07%-7.59M
62.85%-10.99M
39.84%-16.94M
-1.81%-88.48M
94.60%-1.49M
-46.66%-29.26M
-44.01%-29.57M
-49.87%-28.16M
4.35%-86.91M
-21.18%-27.64M
Basic earnings per share
73.17%-0.11
64.29%-0.15
42.86%-0.24
4.51%-1.27
95.12%-0.02
-36.67%-0.41
-35.48%-0.42
-35.48%-0.42
16.88%-1.33
-10.81%-0.41
Diluted earnings per share
73.17%-0.11
64.29%-0.15
42.86%-0.24
4.51%-1.27
95.12%-0.02
-36.67%-0.41
-35.48%-0.42
-35.48%-0.42
16.88%-1.33
-10.81%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -53.18%4.35M47.99%2.77M-5.14%2.4M5.03%31.25M126.62%17.57M-51.19%9.28M22.32%1.87M73.98%2.53M340.05%29.75M416.52%7.75M
Operating revenue -53.18%4.35M47.99%2.77M-5.14%2.4M5.95%31.25M131.55%17.57M-51.12%9.28M24.77%1.87M77.65%2.53M344.27%29.5M415.84%7.59M
Cost of revenue -70.61%2.41M19.91%1.91M-1.55%1.84M51.18%18.08M324.57%6.43M-0.38%8.19M49.06%1.59M61.82%1.87M153.77%11.96M31.77%1.51M
Gross profit 77.80%1.94M209.39%857K-15.33%558K-25.99%13.17M78.59%11.14M-89.90%1.09M-39.78%277K121.14%659K768.75%17.79M1,672.44%6.24M
Operating expense -62.15%11.61M-58.52%13.51M-46.81%16.69M25.78%129.48M23.54%34.86M4.09%30.67M31.05%32.57M53.77%31.38M52.67%102.95M34.08%28.22M
Selling and administrative expenses -16.84%5.65M-34.87%4.75M-22.14%6.84M23.73%31.1M14.95%8.21M16.94%6.8M20.10%7.3M44.12%8.79M6.41%25.13M2.92%7.15M
-General and administrative expense -16.84%5.65M-34.87%4.75M-22.14%6.84M23.73%31.1M14.95%8.21M16.94%6.8M20.10%7.3M44.12%8.79M6.41%25.13M2.92%7.15M
Research and development costs -75.05%5.96M-65.35%8.76M-56.41%9.85M26.44%98.38M26.45%26.65M0.93%23.88M34.59%25.28M57.88%22.59M77.60%77.81M49.43%21.07M
Operating profit 67.31%-9.67M60.82%-12.65M47.49%-16.13M-36.59%-116.31M-7.91%-23.72M-58.42%-29.58M-32.39%-32.29M-52.77%-30.72M-30.24%-85.15M-6.21%-21.98M
Net non-operating interest income expense -14.03%1.99M2.32M
Non-operating interest income -14.03%1.99M------------------2.32M----------------
Other net income (expense) 104.72%94K-38.79%1.67M-131.67%-810K1,665.91%27.47M598.23%28.18M-55.95%-1.99M-29.44%2.73M94.08%2.56M93.12%-1.75M-167.93%-5.66M
Special income (charges) 59.86%-800K-141.75%-200K-450.00%-2.8M503.34%18.96M377.06%19.67M9.41%-1.99M-85.91%479K-33.33%800K80.69%-4.7M-222.73%-7.1M
-Less：Restructuring and merger&acquisition -52.94%800K113.33%200K450.00%2.8M-672.34%-26.9M-470.42%-26.3M-22.73%1.7M55.88%-1.5M33.33%-800K-80.69%4.7M222.73%7.1M
-Less:Impairment of capital assets --------------6.63M------------------0----
-Write off --0--0------1.31M--0--293K--1.02M------0--0
Other non- operating income (expenses) --894K-16.83%1.87M13.20%1.99M188.83%8.51M--------386.15%2.25M1,389.83%1.76M357.97%2.95M1,522.47%1.44M
Income before tax 74.07%-7.59M62.85%-10.99M39.84%-16.94M-2.23%-88.85M93.28%-1.86M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M
Income tax -367K0
Net income 74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M
Net income continuous Operations 74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M
Minority interest income
Net income attributable to the parent company 74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 74.07%-7.59M62.85%-10.99M39.84%-16.94M-1.81%-88.48M94.60%-1.49M-46.66%-29.26M-44.01%-29.57M-49.87%-28.16M4.35%-86.91M-21.18%-27.64M
Basic earnings per share 73.17%-0.1164.29%-0.1542.86%-0.244.51%-1.2795.12%-0.02-36.67%-0.41-35.48%-0.42-35.48%-0.4216.88%-1.33-10.81%-0.41
Diluted earnings per share 73.17%-0.1164.29%-0.1542.86%-0.244.51%-1.2795.12%-0.02-36.67%-0.41-35.48%-0.42-35.48%-0.4216.88%-1.33-10.81%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data